Alcohol-Related Seizures
G. Bråthen
Trondheim University Hospital, and Norwegian University of Science and Technology, Trondheim, Norway
Search for more papers by this authorE. Ben - Menachem
Institute of Clinical Neuroscience, SU/Sahlgrenska Hospital, Gothenburg, Sweden
Search for more papers by this authorE. Brodtkorb
Trondheim University Hospital, and Norwegian University of Science and Technology, Trondheim, Norway
Search for more papers by this authorJ. C. Garcia - Monco
Hospital de Galdacano, Galdacano (Vizcaya), Spain
Search for more papers by this authorP. Halasz
National Institute of Psychiatry and Neurology, Epilepsy Center, Budapest, Hungary
Search for more papers by this authorG. Bråthen
Trondheim University Hospital, and Norwegian University of Science and Technology, Trondheim, Norway
Search for more papers by this authorE. Ben - Menachem
Institute of Clinical Neuroscience, SU/Sahlgrenska Hospital, Gothenburg, Sweden
Search for more papers by this authorE. Brodtkorb
Trondheim University Hospital, and Norwegian University of Science and Technology, Trondheim, Norway
Search for more papers by this authorJ. C. Garcia - Monco
Hospital de Galdacano, Galdacano (Vizcaya), Spain
Search for more papers by this authorP. Halasz
National Institute of Psychiatry and Neurology, Epilepsy Center, Budapest, Hungary
Search for more papers by this authorNils Erik Gilhus MD, PhD
Professor
Department of Clinical Medicine, University of Bergen and Department of Neurology, Haukeland University Hospital, Bergen, Norway
Search for more papers by this authorMichael P. Barnes MD, FRCP
Professor of Neurological Rehabilitation Medical Director
University of Newcastle, Hunters Moor Neurorehabilitation Ltd, Newcastle upon Tyne, UK
Search for more papers by this authorMichael Brainin MD
Professor
Department of Clinical Medicine and Prevention, and Center for Clinical Neurosciences, Donau-Universität Krems, Department of Neurology, Landesklinikum Donauregion Tulln Tulln, Austria
Search for more papers by this authorNils Erik Gilhus MD, PhD
Professor
Department of Clinical Medicine, University of Bergen and Department of Neurology, Haukeland University Hospital, Bergen, Norway
Search for more papers by this authorMichael P. Barnes MD, FRCP
Professor of Neurological Rehabilitation Medical Director
University of Newcastle, Hunters Moor Neurorehabilitation Ltd, Newcastle upon Tyne, UK
Search for more papers by this authorMichael Brainin MD
Professor
Department of Clinical Medicine and Prevention, and Center for Clinical Neurosciences, Donau-Universität Krems, Department of Neurology, Landesklinikum Donauregion Tulln Tulln, Austria
Search for more papers by this authorSummary
This chapter contains sections titled:
-
Background
-
Methods
-
Results
-
References
References
- Lloyd G. Hippocratic Writings. Middlesex, UK: Penguin Books, 1978; p. 222.
- Earnest MP, Yarnell P. Seizure admissions to a city hospital: the role of alcohol. Epilepsia 1976; 17: 387–93.
- Hillbom ME. Occurrence of cerebral seizures provoked by alcohol abuse. Epilepsia 1980; 21: 459–66.
- Bråthen G, Brodtkorb E, Helde G, Sand T, Bovim G. The diversity of seizures related to alcohol use. A study of consecutive patients. Eur J Neurol 1999; 6: 697–703.
- Jallon P, Smadja D, Cabre P, Le Mab G, Bazin M. EPIMART: prospective incidence study of epileptic seizures in newly referred patients in a french caribbean island (Martinique). Epilepsia 1999; 40: 1103–9.
- Leone MA, Bråthen G. Treatment policies for alcohol- related seizures: a survey of European neurologists. Eur J Neurol 2007; 14 (3): e2–3.
- Bråthen G, Ben-Menachem E, Brodtkorb E, et al. EFNS Guideline on the diagnosis and management of alcohol - related seizures: report of an EFNS task force. Eur J Neurol 2005; 12: 575–81.
- Brainin M, Barnes M, Baron J - C, et al. Guidance for the preparation of neurological management guidelines by EFNS scientific task forces–revised recommendations. Eur J Neurol 2004; 11: 577–81.
- Mayfield D, Mcleod G, Hall P. The CAGE questionnaire: validation of a new alcoholism screening instrument. Am J Psychiatry 1974; 131 (10): 1121–3.
- Matano RA, Koopman C, Wanat SF, Whitsell SD, Borgrefe A, Westrup D. Assessment of binge drinking of alcohol in highly educated employees. Addict Behav 2003; 28 : 1299–310.
- Fiellin DA, Reid MC, O'Connor PG. Screening for alcohol problems in primary care: a systematic review. Arch Intern Med 2000; 160 (13): 1977–89.
- MacKenzie D, Langa A, Brown T. Identifying hazardous or harmful alcohol use in medical admissions: a comparison of Audit, CAGE and Brief MAST. Alcohol Alcohol 1996; 31: 591–9.
- Bush K, Kivlahan DR, McDonnel MB, Fihn SD, Bradley KA. The AUDIT alcohol consumption questions (AUDIT - C): an effective brief screening test for problem drinking. Arch Intern Med 1998; 16: 1789–95.
- Hodgson RJ, John B, Abbasi T, et al. Fast screening for alcohol misuse. Addict Behav 2003; 28: 1453–63.
- Piccinelli M, Tessari E, Bortolomasi M, et al. Efficacy of the alcohol use disorders identification test as a screening tool for hazardous alcohol intake and related disorders in primary care: a validity study. BMJ 1997; 314: 420–7.
- Seppa K, Lepisto J, Sillanaukee P. Five - shot questionnaire on heavy drinking. Alcohol Clin Exp Res 1998; 22 (8): 1788–91.
- Feuerlein W, Ringer C, Kufner H, Antons K. Diagnose des Alkoholismus. Der Münchner Alkoholismustest (MALT). Munch Med Wschr 1977; 119: 1275–86.
- Aertgeerts B, Buntinx F, Ansoms S, Fevery J. Questionnaires are better than laboratory tests to screen for current alcohol abuse or dependence in a male inpatient population. Acta Clin Belg 2002; 57: 241–9.
-
Bernadt MW, Mumford J, Taylor C, Smith B, Murray RM. Comparison of questionnaire and laboratory tests in the detection of excessive drinking and alcoholism. Lancet 1982; i: 325–8.
10.1016/S0140-6736(82)91579-3 Google Scholar
- Bråthen G, Bjerve K, Brodtkorb B, Bovim G. Validity of carbohydrate - deficient transferrin and other markers as diagnostic aids in the detection of alcohol - related seizures. J Neurol Neurosurg Psychiatry 2000; 68: 342–8.
- Martin MJ, Heyermann C, Neumann T, et al. Preoperative evaluation of chronic alcoholics assessed for surgery of the upper digestive tract. Alcohol Clin Exp Res 2002; 26: 836–40.
- Salaspuro M. Carbohydrate -deficient transferrin as compared to other markers of alcoholism: a systematic review. Alcohol 1999; 19 (3): 261–71.
- Scouller K, Conigrave KM, Macaskill P, Irwig L, Whitfield JB. Should we use carbohydrate - deficient transferrin instead of G - glutamyltransferase for detecting problem drinkers? A systematic review and metaanalysis. Clin Chem 2000; 46: 1894–902.
- Hietala J, Koivisto H, Anttila P, Niemelä O. Comparison of the combined marker GGT - CDT and the conventional laboratory markers of alcohol abuse in heavy drinkers, moderate drinkers and abstainers. Alcohol Alcohol 2006; 41: 528–33.
- Bentele M, Kriston L, Clement HW, Härter M, Mundle G, Berner MM. The validity of the laboratory marker combinations DOVER and QUVER to detect physician's diagnosis of at-risk drinking. Addict Biol 2007; 12: 85–92.
- Sillanaukee P, Olsson U. Improved diagnostic classification of alcohol abusers by combining carbohydrate - deficient transferrin and G-glutamyltransferase. Clin Chem 2001; 47: 681–5.
- Savola O, Niemelä O, Hillbom M. Blood alcohol is the best indicator of hazardous alcohol drinking in young adults and working aged patients with trauma. Alcohol Alcohol 2004; 39: 340–5.
- FIRST Group. Randomized clinical trial on the efficacy of antiepileptic drugs in reducing the risk of relapse after a first unprovoked tonic - clonic seizure. Neurology 1993; 43: 478–83.
- Orringer CE, Eustace JC, Wunsch CD, Gardner LB. Natural history of lactic acidosis after grand - mal seizures. A model for the study of an anion - gap acidosis not associated with hyperkalemia. N Engl J Med 1977; 297: 796–9.
- Sullivan JT, Sykora K, Schneiderman J, Naranjo CA, Sellers EM. Assessment of alcohol withdrawal: the revised Clinical Institute Withdrawal Assessment for Alcohol scale (CIWA - AR). Br J Addict 1989; 84: 1353–7.
- Victor M, Brausch C. The Role of Abstinence in the Genesis of Alcoholic Epilepsy. Epilepsia 1967; 8: 1–20.
- Claassen CA, Adinoff B. Alcohol withdrawal syndrome. Guidelines for management. CNS Drugs 1999; 12: 279–91.
- Mayo -Smith MF for the American Society of Addiction Medicine Working Group on Pharmacological Management of Alcohol Withdrawal. Pharmacological management of alcohol withdrawal. A meta - analysis and evidence - based practice guideline. JAMA 1997; 278: 144–51.
- Mayo - Smith MF, Beecher LH, Fischer TL, et al. for the Working Group on the Management of Alcohol Withdrawal Delirium, Practice Guidelines Committee, American Society of Addiction Medicine. Management of alcohol withdrawal delirium. An evidence - based practice guideline. Arch Intern Med 2004; 164: 1405–12.
- Scottish Intercollegiate Guidelines Network (SIGN). The Management of Harmful Drinking and Alcohol Dependence in Primary Care. Edinburgh: SIGN, 2002; (SIGN publication No. 74).
- Earnest MP, Feldman H, Marx JA, Harris BS, Biletch M, Sullivan LP. Intracranial lesions shown by CT in 259 cases of first alcohol related seizure. Neurology 1988; 38: 1561.
- Schoenenberger RA, Heim SM. Indication for computed tomography of the brain in patients with first uncomplicated generalised seizure. BMJ 1994; 309: 986–9.
- Hillbom ME, Hjelm - Jaeger M. Should alcohol withdrawal seizures be treated with anti - epileptic drugs? Acta Neurol Scand 1984; 69: 39–2.
- Sand T, Br åthen G, Michler R, Brodtkorb E, Helde G, Bovim G. Clinical utility of EEG in alcohol - related seizures. Acta Neurol Scand 2002; 105: 18–24.
- Torvik A, Lindboe CF, Rogde S. Brain lesions in alcoholics: a neuropathological study with clinical correlations. J Neurol Sci 1982; 56: 233–48.
- Blansjaar BA, Van Dijk JG. Korsakoff-Wernicke syndrome. Alcohol Alcohol 1992; 27: 435–7.
- Harper CG, Giles M, Finlay-Jones R. Clinical signs in the Wernicke - Korsakoff complex: a retrospective analysis of 131 cases diagnosed at necropsy. J Neurol Neurosurg Psychiatry 1986; 49: 341–5.
- Holzbach E. Thiamine absorption in alcoholic delirium patients. J Studies Alcohol 1996; 57: 581–4.
- Ambrose ML, Bowden SC, Whelan G. Thiamin treatment and working memory function of alcohol - dependent people: preliminary findings. Alcohol Clin Exp Res 2001; 25: 112–6.
- Day E, Bentham P, Callaghan R, Kuruvilla T, George S. Thiamine for Wernicke - Korsakoff Syndrome in people at risk from alcohol abuse. Cochrane Database of Systematic Reviews 2004;(1):Art. No.: CD004033. DOI: 10.1002/14651858.CD004033.pub2.
- Lampl C, Yazdi K. Central pontine myelinolysis. Eur Neurol 2002; 47 (1): 3–10.
- Mochizuki H, Masaki T, Miyakawa T, et al. Benign type of central pontine myelinolysis in alcoholism: clinical, neuroradiological and electrophysiological findings. J Neurol 2003; 250: 1077–83.
- Kelly J, Wassif W, Mitchard J, Gardner WN. Severe hyponatremia secondary to beer potomania complicated by central pontine myelinolysis. Int J Clin Pract 1998; 52: 585–7.
- Saeed BO, Beaumont D, Handley GH, Weaver JU. Severe hyponatremia: investigation and management in a district general hospital. J Clin Pathol 2002; 55: 893–6.
- Victor M. The role of hypomagnesemia and respiratory alkalosis in the genesis of alcohol withdrawal symptoms. Ann NY Acad Sci 1973; 215: 235–48.
- Traviesa DC. Magnesium deficiency: a possible cause of thiamine refractoriness in Wernicke - Korsakoff encephalopathy. J Neurol Neurosurg Psychiatry 1974; 37: 959–62.
- Whitfield CL, Thompson G, Lamb A, Spencer V, Pfeifer M, Browning-Ferrando M. Detoxification of 1,024 alcoholic patients without psychoactive drugs. JAMA 1978; 239 (14): 1409–10.
- Hillbom M, Pieninkeroinen I, Leone M. Seizures in alcohol- dependent patients. Epidemiology, pathophysiology and management. CNS Drugs 2003; 17: 1013–30.
- Lechtenberg R, Worner T. Seizure risk with recurrent alcohol detoxification. Arch Neurol 1990; 47: 535–8.
- Mayo - Smith MF, Bernard D. Late onset seizures in alcohol withdrawal. Alcohol Clin Exp Res 1995; 19: 656–9.
- Ntais C, Pakos E, Kyzas P, Ioannidis JP. Benzodiazepines for alcohol withdrawal. Cochrane Database Syst Rev 2005 ;(3):Art. No.: CD005063. DOI: 10.1002/14651858. CD005063.pub2.
- Saitz R, Mayo - Smith MF, Roberts MS, Redmond HA, Bernard DR, Calkins DR. Individualized treatment for alcohol withdrawal. A randomized double - blind controlled trial. JAMA 1994; 272: 519–23.
- Jaeger TM, Lohr RH, Pankratz VS. Symptom-triggered therapy for alcohol withdrawal syndrome in medical inpatients. Mayo Clin Proc 2001; 76: 695–701.
- Polycarpou A, Papanikolau P, Ionannidis JPA, Contopoulos Ioannidis D. Anticonvulsants for alcohol withdrawal. Cochrane Database Syst Rev 2005 ;(3):Art. No.: CD005064. DOI: 10.1002/14651858.CD005064.pub2.
- Holbrook AM, Crowther R, Lotter A, Cheng C, King D. Meta - analysis of benzodiazepine use in the treatment of acute alcohol withdrawal. CMAJ 1999; 160: 649–55.
- Robinson BJ, Robinson GM, Maling TJ, Johnson RH. Is clonidine useful in the treatment of alcohol withdrawal? Alcohol Clin Exp Res 1989; 13: 95–8.
- D'Onofrio G, Rathlev NK, Ulrich AS, Fish SS, Freedland ES. Lorazepam for the prevention of recurrent seizures related to alcohol. N Engl J Med 1999; 340: 915–9.
- Alldredge BK, Lowenstein DH. Status epilepticus related to alcohol abuse. Epilepsia 1993; 34: 1033–7.
- Hesdorffer DC, Logroscino G, Cascino G, et al. Risk of unprovoked seizure after acute symptomatic seizure: effect of status epilepticus. Ann Neurol 1998; 44: 908–12.
- Alldredge BK, Gelb AM, Isaacs SM, et al. A comparison of lorazepam, diazepam, and placebo for the treatment of out - of - hospital status epilepticus. N Engl J Med 2001; 345: 631–7.
- Treiman DM, Meyers PD, Walton NY, et al. A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. N Engl J Med 1998; 339: 792–8.
- Malcolm R, Myrick H, Brady KT, Ballenger JC. Update on anticonvulsants for the treatment of alcohol withdrawal. Am J Addict 2001; 10 (Suppl.): 16–23.
- Mueller TI, Stout RL, Rudden S, et al. A double-blind, placebo - controlled pilot study of carbamazepine for the treatment of alcohol dependence. Alcohol Clin Exp Res 1997; 21 (1): 86–92.
- Brower KJ, Myra Kim H, Strobbe S, Karam - Hage MA, Consens F, Zucker RA. A randomized double-blind pilot trial of gabapentin versus placebo to treat alcohol dependence and comorbid insomnia. Alcohol Clin Exp Res 2008; 32 (8): 1429–38.
- Salloum IM, Cornelius JR, Daley DC, Kirisci L, Himmelhoch JM, Thase ME. Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double - blind placebo - controlled study. Arch Gen Psychiatry 2005; 62 (1): 37–45.
- Martinotti G, Di Nicola M, Tedeschi D, Mazza M, Janiri L, Bria P. Efficacy and safety of pregabalin in alcohol dependence. Adv Ther 2008; 25 (6): 608–18.
- Johnson BA, Rosenthal N, Capece JA, et al. Topiramate for Alcoholism Advisory Board; Topiramate for Alcoholism Study Group. Topiramate for treating alcohol dependence: a randomized controlled trial. JAMA 2007; 298 (14): 1641–51.
- Höppener RJ. The effect of social alcohol use on seizures in patients with epilepsy. In: Porter RJ, Mattson RH, Cramer JA, Diamond I (eds) Alcohol and Seizures. Basic Mechanisms and Clinical Concepts. Philadelphia: F.A. Davis Company, 1990; pp. 222–32.
- Höppener RJ, Kuyer A, van der Lugt PJM. Epilepsy and alcohol: the influence of social alcohol intake on seizures and treatment in epilepsy. Epilepsia 1983; 24: 459–71.
- Turner C. How much alcohol is in a ‘standard drink’? An analysis of 125 studies. Br J Addict 1990; 85: 1171–5.
- Mattson RH, Fay ML, Sturman JK, Cramer JA, Wallace JD, Mattson EM. The effect of various patterns of alcohol use on seizures in patients with epilepsy. In: Porter RJ, Mattson RH, Cramer JA, Diamond I (eds) Alcohol and Seizures. Basic Mechanisms and Clinical Concepts. Philadelphia: F.A. Davis Company, 1990; pp. 233–40.
- Pedersen SB, Petersen KA. Juvenile myoclonic epilepsy: clinical and EEG features. Acta Neurol Scand 1998; 97: 160–3.